Mucus Clearance Devices Market

Industry Outlook

The mucus clearance devices market is set to expand at a compound annual growth rate (CAGR) of 7.3% during the forecast period from 2019 to 2027. According to the latest statistics provided by the World Health Organization report, more than 3 million people die annually due to chronic obstructive pulmonary disease worldwide, which is equivalent to 6% of the deaths occurring throughout the globe.

Market Synopsis

Long-term exposure to lung irritants makes COPD the most critical respiratory disease.

Chronic obstructive pulmonary disease is dominating the indication segment for mucus clearance devices. The chief risk factor that contributes to the occurrence of COPD is long-term exposure to lung irritants, which cause damage to the lower reparatory tracts and lung alveoli. A significant rise in the number of smokers worldwide and increasing air pollution at an alarming rate will further accentuate the incidence rate of COPD throughout the globe. Bronchiectasis has gained tremendous attention in the last decade owing to the constant rise in the number of antibiotic-resistant patients suffering from an acute lung infections.

High-frequency chest wall oscillation (HFCWO) devices are in demand for their excellent ergonomic features, which promise patients comfort and associated concordance.

High-frequency chest wall oscillation devices are leading the product segment in the mucus clearance devices segment. The addition of new ergonomic features, such as vibration at varying intensities and frequencies to the existing devices, promises patient comfort and its associated concordance. Increasing demand from homecare settings and rehabilitation centers further propels the HFCWO devices market’s growth. Oscillating positive expiratory pressure will showcase impressive growth in the near future owing to its twin benefits in patients suffering from cystic fibrosis, such as the clearance of excess fluids from the lungs and a significant reduction in gas trapping, and improvement in ventilation of the lungs.

Growing incidence of chronic pulmonary obstructive disease and a significant rise in the smoking population together drive the market’s growth in North America.

North America accounts for a market share of 35.1% and is the dominant regional segment for the mucus clearance devices market. The growing incidence of chronic pulmonary disease and subsequent growth in the smoking population together drive market growth in the North American region. According to the research findings of the Centers for Disease Control and Prevention (CDC), the 2017 report shows that the number of deaths in the U.S. due to chronic lower respiratory tract disease is 160,201, hence making it the 4th largest cause of death in the region. Europe holds a market share of 29.5%, primarily due to the high prevalence rate of cystic fibrosis in the European Union, which is 0.79 per 10,000 people, as quoted by the European Respiratory Society (ERS). Asia Pacific represents 16.8% of the market share, owing to the significant rise in tobacco consumption and the developing healthcare infrastructure.

Historical and Forecast Period

This research report presents the analysis of each segment from 2017 to 2027, considering 2018 as the base year for the research. The compound annual growth rate (CAGR) for each of the respective segments is calculated for the forecast period from 2019 to 2027.

Report Scope by Segments

The market is segmented by indication, product, and geography. Medical device companies manufacturing mucus clearance devices are Allergan, Plc., Electromed, Inc., Hill-Rom, Inc., Koninklijke Philips N.V., Monaghan Medical Corporation, Respiratory Technologies, Inc., Smiths Medical, Thayer Medical Corporation, and Vortran Medical Technology, Inc.

Key questions are answered in this report.

• Which medical device manufacturers are pioneering the production of mucus-clearance devices?
• What are the strategic collaborations, mergers, and acquisitions happening in the mucus clearance devices market?
• What is the incidence rate of chronic respiratory ailments?
• What are the latest ergonomic features added to the existing mucus clearance devices?
• What is the prevalence rate of COPD and bronchiectasis in developing regional segments?

Chapter 1. Preface
1.1. Report Scope and Description
1.1.1. Purpose of the Report
1.1.2. Target Audience
1.1.3. USP and Key Offerings
1.2. Research Scope
1.3. Research Methodology
1.3.1. Phase I-Secondary Research
1.3.2. Phase II-Primary Research
1.3.3. Approach Adopted
1.3.4. Top-down Approach
1.3.5. Bottom-up Approach
1.3.6. Phase III-Expert Panel Review
1.3.7. Assumptions
1.4. Market Segmentation

Chapter 2. Executive Summary
2.1. Global MCD Market Portraiture
2.2. Global MCD Market, by Indication, 2018 (US$ Mn)
2.3. Global MCD Market, by Product, 2018 (US$ Mn)
2.4. Global MCD Market, by Geography, 2018 (US$ Mn)

Chapter 3. Mucus Clearance Devices (MCD) Market: Dynamics and Future Outlook
3.1. Market Overview
3.2. Drivers
3.3. Challenges
3.4. Opportunities
3.5. Attractive Investment Proposition, by Geography, 2018
3.6. Competitive Analysis: Global MCD Market, by Key Players, 2018

Chapter 4. Global Mucus Clearance Devices (MCD) Market, by Indication
4.1. Overview
4.2. Bronchiectasis
4.3. Cystic Fibrosis
4.4. Chronic Obstructive Pulmonary Disease
4.5. Others

Chapter 5. Global Mucus Clearance Devices (MCD) Market, by Product
5.1. Overview
5.2. High Frequency Chest Wall Oscillation Device
5.3. Intrapulmonary Percussive Ventilation Flutter Device
5.4. Oscillating Positive Expiratory Pressure Device

Chapter 6. Global Mucus Clearance Devices (MCD) Market, by Geography
6.1. Overview
6.2. North America MCD Market Analysis, 2017– 2027
6.2.1. North America MCD Market, by Indication, 2017 – 2027 (US$ Mn)
6.2.2. North America MCD Market, by Product, 2017 – 2027 (US$ Mn)
6.2.3. North America MCD Market, by Country, 2017 – 2027 (US$ Mn)
6.2.3.1. U.S.
6.2.3.2. Canada
6.3. Europe MCD Market Analysis, 2017 – 2027
6.3.1. Europe MCD Market, by Indication, 2017– 2027 (US$ Mn)
6.3.2. Europe MCD Market, by Product, 2017 – 2027 (US$ Mn)
6.3.3. Europe MCD Market, by Country/Region, 2017 – 2027 (US$ Mn)
6.3.3.1. U.K.
6.3.3.2. Germany
6.3.3.3. Rest of Europe
6.4. Asia Pacific MCD Market Analysis, 2017 – 2027
6.4.1. Asia Pacific MCD Market, by Indication, 2017 – 2027 (US$ Mn)
6.4.2. Asia Pacific MCD Market, by Product, 2017– 2027 (US$ Mn)
6.4.3. Asia Pacific MCD Market, by Country/Region, 2017 – 2027 (US$ Mn)
6.4.3.1. China
6.4.3.2. Japan
6.4.3.3. Rest of Asia Pacific
6.5. Latin America MCD Market Analysis, 2017 – 2027
6.5.1. Latin America MCD Market, by Indication, 2017 – 2027 (US$ Mn)
6.5.2. Latin America MCD Market, by Product, 2017 – 2027 (US$ Mn)
6.5.3. Latin America MCD Market, by Country/Region, 2017 – 2027 (US$ Mn)
6.5.3.1. Brazil
6.5.3.2. Mexico
6.5.3.3. Rest of Latin America
6.6. Middle East and Africa MCD Market Analysis, 2017 – 2027
6.6.1. MEA MCD Market, by Indication, 2017 – 2027 (US$ Mn)
6.6.2. MEA MCD Market, by Product, 2017 – 2027 (US$ Mn)
6.6.3. MEA MCD Market, by Country/Region, 2017 – 2027 (US$ Mn)
6.6.3.1. GCC
6.6.3.2. Rest of MEA

Chapter 7. Company Profiles
7.1. Allergan, Plc.
7.1.1. Business Description
7.1.2. Financial Information (Subject to data availability)
7.1.3. Product Portfolio
7.1.4. News Coverage
7.2. Electromed, Inc.
7.3. Hill-Rom, Inc.
7.4. Koninklijke Philips N.V.
7.5. Monaghan Medical Corporation
7.6. Respiratory Technologies, Inc.
7.7. Smiths Medical
7.8. Thayer Medical Corporation
7.9. Vortran Medical Technology 1, Inc.

List of Figures

FIG. 1 Mucus Clearance Devices (MCD) Market: Research Methodology
FIG. 2 MCD: Market Segmentation
FIG. 3 Global MCD Market, by Indication, 2018 (US$ Mn)
FIG. 4 Global MCD Market, by Product, 2018 (US$ Mn)
FIG. 5 Global MCD Market, by Geography, 2018 (US$ Mn)
FIG. 6 Attractive Investment Proposition: by Geography, 2018
FIG. 7 Competitive Analysis: Global MCD Market, by Key Players, 2018
FIG. 8 Global Bronchietasis Market for MCD, 2017 – 2027 (US$ Mn)
FIG. 9 Global Cystic Fibrosis Market for MCD, 2017– 2027 (US$ Mn)
FIG. 10 Global Chronic Obstructive Pulmonary Disease Market for MCD, 2017 – 2027 (US$ Mn)
FIG. 11 Global Other Indication Market for MCD, 2017 – 2027 (US$ Mn)
FIG. 12 Global High Frequency Chest Wall Oscillation MCD, 2017 – 2027 (US$ Mn)
FIG. 13 Global Intrapulmonary Percussive Ventilation Flutter MCD, 2017 – 2027 (US$ Mn)
FIG. 14 Global Oscillating Positive Expiratory Pressure MCD, 2017 – 2027 (US$ Mn)
FIG. 15 U.S. MCD Market, 2017 – 2027 (US$ Mn)
FIG. 16 Canada MCD Market, 2017 – 2027 (US$ Mn)
FIG. 17 U.K. MCD Market, 2017 – 2027 (US$ Mn)
FIG. 18 Germany MCD Market, 2017– 2027 (US$ Mn)
FIG. 19 Rest of Europe MCD Market, 2017 – 2027 (US$ Mn)
FIG. 20 China MCD Market, 2017 – 2027 (US$ Mn)
FIG. 21 Japan MCD Market, 2017 – 2027 (US$ Mn)
FIG. 22 Rest of Asia Pacific MCD Market, 2017 – 2027 (US$ Mn)
FIG. 23 Brazil MCD Market, 2017 – 2027 (US$ Mn)
FIG. 24 Mexico MCD Market, 2017 – 2027 (US$ Mn)
FIG. 25 Rest of Latin America MCD Market, 2017 – 2027 (US$ Mn)
FIG. 26 GCC MCD Market, 2017 – 2027 (US$ Mn)
FIG. 27 Rest of MEA MCD Market, 2017 – 2027 (US$ Mn)

List of Tables

TABLE 1 Global Mucus Clearance Devices (MCD) Market Portraiture
TABLE 2 Global MCD Market, by Indication, 2017 – 2027 (US$ Mn)
TABLE 3 Global MCD Market , by Product, 2017 – 2027 (US$ Mn)
TABLE 4 Global MCD Market, by Geography, 2017 – 2027(US$ Mn)
TABLE 5 North America MCD Market, by Indication, 2017 – 2027 (US$ Mn)
TABLE 6 North America MCD Market, by Product, 2017 – 2027 (US$ Mn)
TABLE 7 North America MCD Market, by Country, 2017 – 2027 (US$ Mn)
TABLE 8 Europe MCD Market, by Indication, 2017 – 2027 (US$ Mn)
TABLE 9 Europe MCD Market, by Product, 2017 – 2027(US$ Mn)
TABLE 10 Europe MCD Market, by Country/Region, 2017 – 2027 (US$ Mn)
TABLE 11 Asia Pacific MCD Market, by Indication, 2017 – 2027 (US$ Mn)
TABLE 12 Asia Pacific MCD Market, by Product, 2017 – 2027 (US$ Mn)
TABLE 13 Asia Pacific MCD Market, by Country/Region, 2017– 2027 (US$ Mn)
TABLE 14 Latin America MCD Market, by Indication, 2017 – 2027 (US$ Mn)
TABLE 15 Latin America MCD Market, by Product, 2017 – 2027 (US$ Mn)
TABLE 16 Latin America MCD Market, by Country/Region, 2017 – 2027 (US$ Mn)
TABLE 17 Middle East and Africa MCD Market, by Indication, 2017 – 2027 (US$ Mn)
TABLE 18 Middle East and Africa MCD Market, by Product, 2017 – 2027 (US$ Mn)
TABLE 19 Middle East and Africa MCD Market, by Country/Region, 2017 – 2027 (US$ Mn)
TABLE 20 Allergan, Plc.: Company Snapshot (Business Description; Financial Information; Product Portfolio; Key Developments)
TABLE 21 Electromed, Inc.: Company Snapshot (Business Description; Financial Information; Product Portfolio; Key Developments)
TABLE 22 Hill-Rom, Inc.: Company Snapshot (Business Description; Financial Information; Product Portfolio; Key Developments)
TABLE 23 Koninklijke Philips N.V.: Company Snapshot (Business Description; Financial Information; Product Portfolio; Key Developments)
TABLE 24 Monaghan Medical Corporation: Company Snapshot (Business Description; Financial Information; Product Portfolio; Key Developments)
TABLE 25 Respiratory Technologies, Inc.: Company Snapshot (Business Description; Financial Information; Product Portfolio; Key Developments)
TABLE 26 Smiths Medical: Company Snapshot (Business Description; Financial Information; Product Portfolio; Key Developments)
TABLE 27 Thayer Medical Corporation: Company Snapshot (Business Description; Financial Information; Product Portfolio; Key Developments)
TABLE 28 Vortran Medical Technology 1, Inc.: Company Snapshot (Business Description; Financial Information; Product Portfolio; Key Developments)